BIO chief Mc­Mur­ry-Heath on leave as storm clouds gath­er over group’s di­rec­tion, leg­isla­tive set­back

Af­ter a short, rocky two-year tenure high­light­ed by an event-killing pan­dem­ic, cut­backs and new pric­ing leg­is­la­tion wide­ly viewed in biotech as a calami­ty, BIO CEO Michelle Mc­Mur­ry-Heath has gone on leave in what may be a step ahead of her quick ex­it.

In a state­ment is­sued to End­points News Sun­day, BIO said:

The BIO CEO is cur­rent­ly on leave. BIO does not spec­u­late on ru­mors rel­a­tive to em­ploy­ees or per­son­nel. BIO re­mains vig­i­lant in its ad­vo­ca­cy for biotech in­no­va­tion and the well­be­ing of pa­tients.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER